ALPHARETTA, Ga., Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal ...
In addition to these financial developments, Avanos Medical has received FDA approval for the CORGRIP SR Nasal Bridle System, which is expected to contribute to long-term growth. The company is ...
In addition to these financial developments, Avanos Medical has received FDA approval for the CORGRIP SR Nasal Bridle System, which is expected to contribute to long-term growth. The company is also ...